Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Again. The company has been working hard with several BP over the past 2-3 years. The shuffle has to be intense as one oversteps the other and we will all find out just how intense it has been upon release of SEC documents if and when a deal is inked.
Stay tuned. IBD added to this specific deal is a dream come true for me. OM only would be great but IBD is the cash cow imo. Hope they announce the deal in October
Thank you. Saved me time when I get home. I meant around 160K which thank you. Again.
SS - is that not after IF all milestones HIT? I’ll have to look when I get home.
Long and stronger than ever here!!! This is what I was explaining to a few of my co-LONG's.
I am in the camp that we will not meet any milestones for the good of the company. The initial milestone agreement was good at the time and we received a lump sum of 2 million dollars that day which would have taken Leo a much much longer time to get if he kept the slow drip on with the original agreement. I believe that the negotiations turned in our favor and we have now included the IBD portion of our pipeline with the OM indication. Based on recent IBD deals and some in pre-clinical, this can be an unbelievably lucrative indication. As I stated, if it was just B-OM we could have seen 10-20-30 million upfront maybe more with less backend, who knows...but adding IBD and depending on how the deal is structured this could be our jack pot if the ink drys.
Now with the above in thought, why would Leo try to exhaust himself and shareholders to dilute at these levels to gain the 1-2-2 million milestones if we are about to close a 100 million plus deal?
I would assume that just like the original agreement stated that the partner will be taking all costs for formulation, trials and NDA which makes this a no brainer for us shareholders. This will open up Prurisol and Kevetrin for IPIX to continue on.
For me and I am sorry to some of my Long friends here, I do not want to see any milestone's hit this month because at the current 5 day average --- that will be 15 million more shares into Aspires hands. I'd like to just stay at 160million OS, put some of of the Directors from the partnering company on the BOD and uplist when the deal hits and call it a day ....
IPIX is scheduling an end of phase meeting for OM so hopefully we get our answer on BTD at that time.
I am confident based on recent deals that we will get paid handsomely when the deal inks.
Good luck to all Longs.
My assumption is we will not hit any bc we won’t need that garbage cash diluting at .24. The first news will be the mega B deal and we will not need to dilute any further. The 160 plus will be our number. No more from Aspire.
My gut
I don’t follow. IBD was added to the mix. Now instead of a 20-30-40 million upfront, for only OM, we have a partner for turning B into a powerhouse for IBD. This was Arthur’s plan in anchoring and they now have a serious suitor with a signed term sheet. Big news.
The milestones will be of zero concern once the ink dries and I expect it to dry soon. We went from cda to negotiations to term sheet. Right on par. But now we added IBD. Huge money
So if my example happens. We don’t need milestone dilution from Aspire.
I could be way off and we still hit BTD and have already paid the CRO since June 30th.....but I’m guessing ipix is all in on this IBD and OM deal
So the freak out! Why are we freaking out? No cash? Can’t provide P results without cash?
Here is what will happen. IMO
We sign a mega deal for B OM and IBD with insane milestones based on formulation and trial advancement. This deal will be based on product value like all other recent drugs
The deal will be in the 100,s of millions upfront with much much more on milestones. The addition of IBD is as recent as August. Things change and this BP is serious.
SS. That could be very different meetings. I think and end of phase meeting closes down and we get direction on next phase. Hoping for Priority Review.
Yes in the k.
The fact they state they are REQUESTING AN END OF TRIAL MEETING in Sept with fda for OM means something. Why did they wait so long? And now is time?
I’m sure this meeting would have to have details on possible partners and direction moving forward.
Anyone??????
Does this mean they find out if they get BTD now?
It’s just crazy how long this took to request a meeting. I’d say something is up and ready to rock
Good writ-up. I’ve been around long enough to know there really is nothing bad in that K. This will pass and I would not be surprised if we get some really good news soon and everyone who sold will be crying.
The fact IBD is in the picture is phenomenal.
I was reaching out to IPIX for clarification on this whole thing. They state they are "unlikely" going to hit any milestones prior to the 30th. So what is the worst case scenario right now if we hit zero milestones before the 30th in regards to shares? The 8 million for 2 million? meaning .25?
They are requesting an end of phase 2 meeting with the FDA this month, so I doubt we hear about BTD. jmo
Signed agreements in August, do we really think a deal can be done in under 30 days?
Bright spot:
And IBD!!! Huge $$$$$$. Told you all....a super B deal in the works.
I guarantee that iPIX has the ability to publish Pasi 75 results by 9/30. That is all that is needed to successfully meet the said milestone (w good results). It's specific in the purchase agreement. Just have a meaningful response comparable to placebo at 75% reduction at 12 weeks. IPIX could layout that data set tonight IMO. I think there is a method to this madness and I am feeling a little nervous. It will come when it comes and I hope this month and I hope there truly is a plan to take this company to the Nasdaq with several partnerships this year adding several to the BOD table. I'd love for some public buys from partners and new directors
I think your record states otherwise. But thanks. 3 weeks left in September. I say Wed or Thurs it begins.
I thought it was .40? Now it’s .60
Wholly sh1t. What happened here?
Was in meetings all day
I’m on opposite side. I think things are so good it has been the reason for delays and silence. If we see anything over 50% pasi 75 and see anything over 20% pasi 90 I will be right. That’s an overnight buyout possibility in the 5-10 billion maybe more due to 505. IMO. Oral drugs don’t post those numbers. Biologics do.
If we see 10-15% pasi 75 all yous are right.
I had one suggestion about a year ago to Leo. Release a PR in the AM that is basically what your iHub followers call FLUFF. And then after hours release a partnership news or something game changing.
Hoping today is that day ;)
IMO. I’ve been pegged as wrong for so long...it’s about time to be right;)
As Leo and others have said...these boards are mostly pure garbage and full of agendas.
Good news. We are a day closer to finding out what is going on.
It’s dead silent for a reason. Leo will not take any chances!!! IMO.
I bet they have 2 of the 3 ready but have the order in which they want...which requires a lil more patience.
Ipix and Leo will get this party started shortly. In the mean time...sit back, relax...and put your tray tables down and enjoy the ride.
Bigger and better news than what anyone thinks....imo.
Now read page 10of same agreement. It explains terms:
7. CERTAIN DEFINED TERMS.
For purposes of this Agreement, the following terms shall have the following meanings:
(a) “1933 Act” means the Securities Act of 1933, as amended.
(b) “Bankruptcy Law” means Title 11, U.S. Code, or any similar federal or state law for the relief of debtors.
(c) “BD Agreement” means a significant licensing arrangement with a pharmaceutical company that will include an initial (“up-front”) payment to the Company in an amount in the double-digits millions of dollars and will arrange for such pharmaceutical company to undertake the continuing development of the Company’s Brilacidin compound in the indication of Oral Mucositis, including the conducting and funding of clinical trials aiming towards the filing of an NDA.
10
(d) “Break-through Designation” means the granting by the U.S. Food and Drug Administration of the Company’s request for Breakthrough Therapy Designation for the Company’s Brilacidin compound in the indication of Oral Mucositis.
(e) “Business Day” means any day on which the Principal Market is open for trading during normal trading hours (i.e., 9:30 a.m. to 4:00 p.m. Eastern Time), including any day on which the Principal Market is open for trading for a period of time less than the customary time.
(f) “Date of Announcement” means the date on which an announcement by the Company is made regarding the Break-through Designation, Successful Phase 2b or BD Agreement milestones. For purposes of this definition, if the Company announces a milestone before the Principal Market is open for trading during normal trading hours, the “Date of Announcement” shall be that Business Day. If the Company announces a milestone during the Principal Market’s normal trading hours, or after the Principal Market’s normal trading hours, then the “Date of Announcement” shall be the following Business Day.
Who says it’s Pfizer or Amgen?
Read the damn security purchase agreement. It’s much more specific in regards to the BD agreement:
3rd milestone:
Provided that on or before September 30, 2018, the Company announces the BD Agreement, and provided that the closing price of the Common Stock on such Date of Announcement was equal to or greater than $0.50, then, on or before the second Business Day after the Company announces the BD Agreement, the Company shall sell to the Buyer, and the Buyer shall purchase from the Company, the Fourth Purchase Shares and the Buyer shall pay to the Company as the purchase price therefor, via wire transfer, Two Million Dollars ($2,000,000) (the “Fourth Purchase Shares Purchase Price”). At the Buyer’s discretion, in lieu of purchasing the Fourth Purchase Shares or part thereof, the Buyer may elect to purchase Pre-Funded Warrants. The price for each Pre-Funded Warrant purchased in lieu of Fourth Purchase Shares will be the result of multiplying (x) the number of warrant shares that the Buyer may purchase under such Pre-Funded Warrant by (y) a number equal to the Fourth Purchase Price reduced by $0.01. The exercise price for each warrant share will be $0.01, and the Fourth Purchase Shares Purchase Price shall be reduced by the aggregate exercise price for the Pre-Funded Warrants purchased in lieu of Fourth Purchase Shares.
You should follow the specifics in the agreement and not just a PR. The terms are more important than ipix announcing the summary of the agreement.
Again reread that 8-K detail of milestone for Business Development partnership. It is quite specific. So, I believe and have strong beliefs that everything is set and there are a few variables yet to tidy up.
By End of Sept, we shall have our answer. Am I right or are you.
Costly????? Read again what is happening. The BP will take on all costs and development of B-OM. We take upfront cash. We sit back overlook and start collecting milestone and royalties. Done.
c) “BD Agreement” means a significant licensing arrangement with a pharmaceutical company that will include an initial (“up-front”) payment to the Company in an amount in the double-digits millions of dollars and will arrange for such pharmaceutical company to undertake the continuing development of the Company’s Brilacidin compound in the indication of Oral Mucositis, including the conducting and funding of clinical trials aiming towards the filing of an NDA”
If we hit those numbers I will retire quickly. I hope you are right, but let’s try to beat the 24% at week 12. I think we have a secondary for week 12. Or just beat 33% pasi 75 at week16. The safety is key to blowing up Otezla and stealing market share.
Good thing we are not selling outright. As it says:
(c) “BD Agreement” means a significant licensing arrangement with a pharmaceutical company that will include an initial (“up-front”) payment to the Company in an amount in the double-digits millions of dollars and will arrange for such pharmaceutical company to undertake the continuing development of the Company’s Brilacidin compound in the indication of Oral Mucositis, including the conducting and funding of clinical trials aiming towards the filing of an NDA”
We are unloading BOM for someone else to do the leg work. While ipix collects CASH!
What do you make of this from 8-K?
(c) “BD Agreement” means a significant licensing arrangement with a pharmaceutical company that will include an initial (“up-front”) payment to the Company in an amount in the double-digits millions of dollars and will arrange for such pharmaceutical company to undertake the continuing development of the Company’s Brilacidin compound in the indication of Oral Mucositis, including the conducting and funding of clinical trials aiming towards the filing of an NDA”
It is so detailed, yet the PR said
Lesser upfront. Nothing else. Look at data and compare to competition. We are leaders in an UNTAPPED market. Plus we tested for prevention. Big difference. Mouth cancer on the rise means big money.
$2 million upon announcement of the Company entering into a licensing arrangement with a pharmaceutical company for any of the Company’s clinical assets that will include an initial payment to the Company of an amount in the double-digits millions of dollars.
And in detail in the 8-K:
(c) “BD Agreement” means a significant licensing arrangement with a pharmaceutical company that will include an initial (“up-front”) payment to the Company in an amount in the double-digits millions of dollars and will arrange for such pharmaceutical company to undertake the continuing development of the Company’s Brilacidin compound in the indication of Oral Mucositis, including the conducting and funding of clinical trials aiming towards the filing of an NDA.
THAT MY FRIEND IS PRETTY DETAILED.........I'D SAY THEY ARE JUST WAITING TO SEE IF BTD IS GRANTED AND THE DEAL IS DONE!
There will actually be one more huge piece of news imo. Today the dog days of summer end. I will expect the start of news roll out next week or the following imo.
We have waited patiently and now we can expect that watershed moment
All 3 will be met. It’s in the bank.
Lol. Exactly. My first position is coming up to 7-8 years. 92 million shares out at that time. I had maybe 3-4 thousand shares. I bought some in the 3-4 dollar range when the OS was in the 117 million os range. Now I’m buying 10’s of thousands of shares in the .30-.40 range yet the amount of shares on increased by 30-40 million.
So I’m doing very well in ratio to price and how many shares I acquired to the amount added to the OS. Boom time is near. Imo
What valuations? Please check Otezla’s revenue. It is a blockbuster.
I said let’s pretend P shows 45% PASI 75 at 12 weeks. Not 16. I asked a good question that nobody knows. What would Prurisol be valued at?
Please let me know your thoughts.